Clinical Trial Update: Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on IDP 118 for plaque psoriasis showing safety and efficacy results. Completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IDP-118 (IDP-118)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-20